Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Treah Haggerty, Cara L. Sedney, Abigail Cowher, Dylan Holland, Laura Davisson & Patricia Dekeseredy. (2023) Twitter and Communicating Stigma about Medications to Treat Obesity. Health Communication 38:14, pages 3238-3242.
Read now
Read now
Bruno Halpern & Thiago Bosco Mendes. (2022) Obesity, weight loss and gynecologic neoplasms: a narrative review. Women & Health 62:5, pages 372-383.
Read now
Read now
Xinyi Li & Nicholas T. Bello. (2020) Anorectic state of obesity medications in the United States. Are leaner times ahead?. Expert Opinion on Pharmacotherapy 21:2, pages 167-172.
Read now
Read now
Bruno Halpern & Marcio C. Mancini. (2017) Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release. Expert Opinion on Drug Safety 16:1, pages 27-39.
Read now
Read now
Nasreen Alfaris, Alyssa M Minnick, Christina M Hopkins, Robert I Berkowitz & Thomas A Wadden. (2015) Combination phentermine and topiramate extended release in the management of obesity. Expert Opinion on Pharmacotherapy 16:8, pages 1263-1274.
Read now
Read now
Articles from other publishers (11)
Hong KanJay P. BaeJulia P. DunnErin K. BuysmanNoelle N. GronroosJason P. SwindleLindsay G.S. BengtsonNadia Ahmad. (2023) Real-world primary nonadherence to antiobesity medications. Journal of Managed Care & Specialty Pharmacy, pages 1-10.
Crossref
Crossref
Bruno Halpern, Marcio C. Mancini, Simone van de Sande-Lee & Paulo Augusto Carvalho Miranda. (2023) “Anti-obesity medications” or “medications to treat obesity” instead of “weight loss drugs” – why language matters – an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM). Archives of Endocrinology and Metabolism 67:4.
Crossref
Crossref
Dushyant Kshatriya, Lihong Hao & Nicholas T. Bello. (2023) Metabolic gene signature in white adipose tissue of oral doses raspberry ketone [4-(4-hydroxyphenyl)-2-butanone] that prevent diet-induced weight gain and induce loss of righting reflex. Food and Chemical Toxicology 171, pages 113540.
Crossref
Crossref
Bruno Halpern, Marcio C. Mancini, Maria Edna de Melo, Rodrigo N. Lamounier, Rodrigo O. Moreira, Mario K. Carra, Theodore K. Kyle, Cintia Cercato & Cesar Luiz Boguszewski. (2022) Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO). Archives of Endocrinology and Metabolism.
Crossref
Crossref
Wen Zhang, Xi Chen, Cunchuan Wang, Lilian Gao, Weiju Chen & Wah Yang. (2021) Perceptions and Attitudes Toward Obesity and its Management in Migrants and Rural Residents in China: a Cross-sectional Pilot Study. Obesity Surgery 32:1, pages 152-159.
Crossref
Crossref
Bruno Halpern, Maria Laura da Costa Louzada, Pablo Aschner, Fernando Gerchman, Imperia Brajkovich, José Rocha Faria‐Neto, Felix Escaño Polanco, Julio Montero, Silvia María Marín Juliá, Paulo Andrade Lotufo & Oscar H. Franco. (2020) Obesity and COVID‐19 in Latin America: A tragedy of two pandemics—Official document of the Latin American Federation of Obesity Societies. Obesity Reviews 22:3.
Crossref
Crossref
Bruno Halpern & Marcio C. Mancini. (2020) Should the Same Safety Scrutiny of Antiobesity Medications be Applied to Other Chronic Usage Drugs?. Obesity 28:7, pages 1171-1172.
Crossref
Crossref
Samantha Hocking, Anthony Dear & Michael A. Cowley. (2017) Current and emerging pharmacotherapies for obesity in Australia. Obesity Research & Clinical Practice 11:5, pages 501-521.
Crossref
Crossref
Saleem Ahmad, William N. Washburn, Andres S. Hernandez, Sharon Bisaha, Khehyong Ngu, Wei Wang, Mary Ann Pelleymounter, Daniel Longhi, Neil Flynn, Anthony V. Azzara, Kenneth Rohrbach, James Devenny, Suzanne Rooney, Michael Thomas, Susan Glick, Helen Godonis, Susan Harvey, Hongwei Zhang, Brian Gemzik, Evan B. Janovitz, Christine Huang, Lisa Zhang, Jeffrey A. Robl & Brian J. Murphy. (2016)
Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-
d
]pyrimidin-4(3
H
)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor
. Journal of Medicinal Chemistry 59:19, pages 8848-8858.
Crossref
Crossref
S. Gupta & Z. Wang. (2016) Treatment satisfaction with different weight loss methods among respondents with obesity. Clinical Obesity 6:2, pages 161-170.
Crossref
Crossref
José E. Rodríguez & Kendall M. Campbell. (2016) Past, Present, and Future of Pharmacologic Therapy in Obesity. Primary Care: Clinics in Office Practice 43:1, pages 61-67.
Crossref
Crossref